TechnipFMC plc
FTITechnipFMC plc is printing record margins on a fuller multiple. From here the earnings must do all the lifting.
The sharpest disagreement: the price moved +98.2% in a year while annual EPS moved +20.4% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (68 weeks in) while the P/E sits at the 55th percentile of its own 3-year range. Underneath, the last four quarters read improving — profit +85.7% year on year, and 184% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
TechnipFMC plc trades at $70.0, in a confirmed uptrend and 68 weeks into that stage. That is +16.1% against its own 200-day average. It sits at 84% of a 52-week range of $35 to $77. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (8 weeks and counting).
Today the stock is in a confirmed uptrend — week 68 of stage 2. At $70.0 it trades +16.1% versus its 200-day average and sits at 84% of its 52-week range ($35–$77).
Against the market, two honest reads. Cumulative: over the last 9.5 years the stock moved +105% while the S&P 500 moved +240% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (8 weeks and counting; last ahead the week of 2026-06-12) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
TechnipFMC plc trades at 24.4× P/E, mid-range by its own standards (55th percentile). Its long-run median P/E is 22.1×, measured across 2.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 24.4× is mid-range by its own standards (55th percentile), against a long-run median of 22.1× measured over 2.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved +20.4% against a +98.2% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
TechnipFMC plc reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE lifting at 27.5% — the per-curve reads carry the story. The read is built from 12 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +9.4% | +14.0% | — | — |
| Profit | +12.8% | — | — | — |
| EPS | +20.4% | — | — | — |
| Stock price | +98.2% | +56.4% | +58.5% | — |
4-Factor Sector Score
61.5/100 — rank 4 of 30 in Oil & Gas Equipment & Services · 58% evidence confidence
TechnipFMC plc scores 61.5 out of 100 against the 30 companies it is compared with in Oil & Gas Equipment & Services, ranking 4. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 22.1 + 14.7 + 10.4 + 14.3 = 61.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
TechnipFMC plc reported $2.5 B of revenue in the Mar 26 quarter, +11.7% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 11.6% a year. The last full year, FY25, came in at $9.9 B. The last four reported quarters add to $10.2 B.
FY25 revenue came in at $9.9 B (+9.4% on the year), capping 4 years at 11.6% compound. The latest quarter (Mar 26) printed $2.5 B, +11.7% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +9.8% growth against the decade's 11.6% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +9.8% over the last 4 quarters against +11.8%/yr over the last 8 — stabilising; TTM profit +21.2% vs +153.7%/yr — rolling over.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
TechnipFMC plc's operating margin is 14.1% in the Mar 26 quarter, +2.4 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 0.5% to 13.3%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 14.1%, +2.4 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 0.5%–13.3%, and FY25's 13.3% is the top of that band — a record year.
Why the margin moved: operating margin went +2.4 pp year on year while gross margin went +3.1 pp — the gain came mostly from the gross line: input costs and pricing.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
TechnipFMC plc earned $0.3 B of net profit in the Mar 26 quarter, +85.7% year on year. Full-year FY25 profit was $1.0 B. The 4-year compound rate is 81.2%. That is 10.4% of the quarter's revenue. The same quarter a year earlier earned $0.1 B. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.3 B, +85.7% year on year. On the full year, FY25 printed $1.0 B (+12.8%), and the 4-year compound rate is 81.2%.
Why profit moved: revenue contributed +11.7% and the margin +2.4 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +29.4% vs revenue +9.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 184% of TechnipFMC plc's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $1.8 B of operating cash against $1.0 B of profit. After $0.3 B of capital spending, $1.5 B was left as free cash.
FY25: operating cash of $1.8 B against reported profit of $1.0 B, leaving free cash of $1.5 B after $0.3 B of capital spending. Across the last 3 fiscal years the conversion rate is 184% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
TechnipFMC plc does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 3.4% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
TechnipFMC plc earns a ROE of 28% in FY25. That is up from a trough of −1% in FY22. Return on invested capital clears the cost of that capital by +26.0 percentage points, so growth here adds value rather than only size. The wiring behind it is 9.8% net margin on 0.98× asset turns.
FY25 ROE is 28%, recovered from a FY22 trough of −1% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 9.8% net margin × 0.98× asset turns × 2.97× balance-sheet leverage ≈ 28.5% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 33.9% − 7.9% = a +26.0 pp spread. The 7.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
TechnipFMC plc paid $0.20 per share over the last four reported quarters. The most recent declaration was $0.05 for Mar 26. Against the current price of $70.0 that is a trailing yield of 0.29%, measured on dividends already paid rather than on a forecast.
TechnipFMC plc paid $0.20 per share across the last four reported quarters, most recently $0.05 for Mar 26. Against the current price of $70.0 the trailing twelve months work out to 0.29% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
TechnipFMC plc carries total debt of $1.2 B against shareholder equity of $3.3 B as of Jun 26, a debt-to-equity of 0.38. On the annual view that ratio went from 0.81 in FY21 to 0.39 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $1.2 B against shareholder equity of $3.3 B — a debt-to-equity of 0.38. On the annual view, debt-to-equity went from 0.81 (FY21) to 0.39 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
4.4% of TechnipFMC plc's tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 3.4 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 4.4% of the float is sold short, and at typical trading volumes it would take about 3.4 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
TechnipFMC plc: the Z-score reads 2.84. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.84 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.84.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Archrock, Inc.AROC | 63.3/100Mixed-positive evidence81% evidence | ASLEEP | 21.4/35 Revenue 22.6% · PAT 60.1% · OPM change -1.3 pp 83% evidence | 15.9/25 ROCE 3.2% · OPM 33.8% 76% evidence | 14.7/20 P/E 18.9× · PEG 0.34 65% evidence | 11.3/20 RS sector -4% · RS bench 4.5% · 1Y 53.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 21.4 + 15.9 + 14.7 + 11.3 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2National Energy Services Reunited Corp.NESR | 62.4/100Mixed-positive evidence81% evidence | BREAKING OUT | 19.5/35 Revenue 8.9% · PAT -15.6% · OPM change 2 pp 83% evidence | 10.9/25 ROCE 2.8% · OPM 8.9% 76% evidence | 13.6/20 P/E 33× · PEG 0.4 65% evidence | 18.4/20 RS sector 29.9% · RS bench 37.5% · 1Y 332.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 10.9 + 13.6 + 18.4 = 62.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Cactus, Inc.WHD | 61.8/100Thin evidence · provisional58% evidence | TURNING | 18.0/35 Revenue — · PAT — · OPM change -11.8 pp 45% evidence | 15.3/25 ROCE 4.5% · OPM 12.7% 76% evidence | 9.7/20 P/E 43.8× · PEG — 15% evidence | 18.8/20 RS sector 11.6% · RS bench 22.4% · 1Y 74.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 15.3 + 9.7 + 18.8 = 61.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4TechnipFMC plcthis pageFTI | 61.5/100Thin evidence · provisional58% evidence | ASLEEP | 22.1/35 Revenue — · PAT — · OPM change 2.4 pp 45% evidence | 14.7/25 ROCE 9.8% · OPM 14.1% 76% evidence | 10.4/20 P/E 23× · PEG — 15% evidence | 14.3/20 RS sector 4.7% · RS bench 12.4% · 1Y 100.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 14.7 + 10.4 + 14.3 = 61.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Oceaneering International, Inc.OII | 60.6/100Thin evidence · provisional58% evidence | BREAKING OUT | 15.8/35 Revenue — · PAT — · OPM change -2.6 pp 45% evidence | 13.3/25 ROCE 4.9% · OPM 8.3% 76% evidence | 11.5/20 P/E 11.6× · PEG — 15% evidence | 20.0/20 RS sector 32.6% · RS bench 43.3% · 1Y 136.1%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 13.3 + 11.5 + 20 = 60.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Tidewater Inc.TDW | 58.7/100Mixed-positive evidence81% evidence | ASLEEP | 14.2/35 Revenue -0.9% · PAT 69.7% · OPM change -4.4 pp 83% evidence | 12.8/25 ROCE 3.1% · OPM 18.1% 76% evidence | 14.5/20 P/E 14× · PEG 0.43 65% evidence | 17.2/20 RS sector 4.6% · RS bench 13.9% · 1Y 46.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 12.8 + 14.5 + 17.2 = 58.7 · Decision use: Price leads the evidence: RS versus the benchmark is 13.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Tenaris S.A.TS | 58.1/100Mixed-positive evidence81% evidence | ASLEEP | 17.5/35 Revenue 1.3% · PAT 9.5% · OPM change 0 pp 83% evidence | 15.4/25 ROCE 3.2% · OPM 18.8% 76% evidence | 12.5/20 P/E 15.2× · PEG 0.89 65% evidence | 12.7/20 RS sector 0.6% · RS bench 8.7% · 1Y 62.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 15.4 + 12.5 + 12.7 = 58.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8USA Compression Partners, LPUSAC | 56.5/100Mixed-positive evidence81% evidence | BASING | 22.8/35 Revenue 12.1% · PAT 34.4% · OPM change -0.7 pp 83% evidence | 15.0/25 ROCE 3% · OPM 27.6% 76% evidence | 12.6/20 P/E 28× · PEG 0.66 65% evidence | 6.1/20 RS sector -16.7% · RS bench -7.7% · 1Y 8.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 15 + 12.6 + 6.1 = 56.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -16.7% and the one-year return is 8.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 9Solaris Energy Infrastructure, Inc.SEI | 56.3/100Mixed-positive evidence81% evidence | ASLEEP | 26.8/35 Revenue 86.5% · PAT 100% · OPM change 8.3 pp 83% evidence | 13.3/25 ROCE 2.8% · OPM 25.8% 76% evidence | 12.4/20 P/E 63.5× · PEG 0.5 65% evidence | 3.8/20 RS sector -11% · RS bench -3.7% · 1Y 93.1%7 of 12 weeks ahead 100% evidence |
| Exact sum: 26.8 + 13.3 + 12.4 + 3.8 = 56.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -11% and the one-year return is 93.1%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 10Baker Hughes CompanyBKR | 52.3/100Thin evidence · provisional58% evidence | ASLEEP | 19.0/35 Revenue — · PAT — · OPM change 11.1 pp 45% evidence | 14.1/25 ROCE 3% · OPM 20.6% 76% evidence | 10.7/20 P/E 17.9× · PEG — 15% evidence | 8.5/20 RS sector -7.4% · RS bench 1.5% · 1Y 42.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 14.1 + 10.7 + 8.5 = 52.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11LandBridge Company LLCLB | 51.0/100Mixed-positive evidence64% evidence | BREAKING OUT | 17.5/35 Revenue 54.5% · PAT — · OPM change 0.2 pp 62% evidence | 12.0/25 ROCE 2.5% · OPM 57.2% 76% evidence | 9.4/20 P/E 71.2× · PEG — 15% evidence | 12.1/20 RS sector -5% · RS bench 4.4% · 1Y 42.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 12 + 9.4 + 12.1 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Halliburton CompanyHAL | 50.8/100Thin evidence · provisional58% evidence | ASLEEP | 22.3/35 Revenue — · PAT — · OPM change 4.6 pp 45% evidence | 14.9/25 ROCE 3.9% · OPM 12.6% 76% evidence | 10.8/20 P/E 17.8× · PEG — 15% evidence | 2.8/20 RS sector -15.2% · RS bench -8.1% · 1Y 54.8%3 of 12 weeks ahead 100% evidence |
| Exact sum: 22.3 + 14.9 + 10.8 + 2.8 = 50.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Kodiak Gas Services, Inc.KGS | 50.2/100Mixed-positive evidence81% evidence | ASLEEP | 21.0/35 Revenue 3.9% · PAT 32.7% · OPM change 3.8 pp 83% evidence | 11.8/25 ROCE 2.6% · OPM 30.9% 76% evidence | 6.6/20 P/E 78.8× · PEG 1.99 65% evidence | 10.8/20 RS sector 1.4% · RS bench 8.6% · 1Y 83.4%6 of 12 weeks ahead 100% evidence |
| Exact sum: 21 + 11.8 + 6.6 + 10.8 = 50.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Select Water Solutions, Inc.WTTR | 48.4/100Mixed-negative evidence64% evidence | LEADER | 14.9/35 Revenue -4.1% · PAT — · OPM change 0.7 pp 62% evidence | 5.9/25 ROCE 1.3% · OPM 4.9% 76% evidence | 9.2/20 P/E 72.9× · PEG — 15% evidence | 18.4/20 RS sector 14.1% · RS bench 22.8% · 1Y 121%11 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 5.9 + 9.2 + 18.4 = 48.4 · Decision use: Price leads the evidence: RS versus the benchmark is 22.8%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15SLB N.V.SLB | 48.1/100Thin evidence · provisional58% evidence | ASLEEP | 16.3/35 Revenue — · PAT — · OPM change -1.5 pp 45% evidence | 12.4/25 ROCE 2.8% · OPM 11.8% 76% evidence | 10.5/20 P/E 22.5× · PEG — 15% evidence | 8.9/20 RS sector -6% · RS bench 2.4% · 1Y 54.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 12.4 + 10.5 + 8.9 = 48.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16NOV Inc.NOV | 47.3/100Thin evidence · provisional58% evidence | ASLEEP | 17.3/35 Revenue — · PAT — · OPM change -4.9 pp 45% evidence | 8.5/25 ROCE 2.2% · OPM 2.3% 76% evidence | 9.3/20 P/E 71.3× · PEG — 15% evidence | 12.2/20 RS sector -4.5% · RS bench 4.2% · 1Y 68%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.3 + 8.5 + 9.3 + 12.2 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Bristow Group Inc.VTOL | 46.3/100Mixed-negative evidence75% evidence | TURNING | 14.0/35 Revenue 6.8% · PAT 0.9% · OPM change -0.7 pp 83% evidence | 7.9/25 ROCE 1.8% · OPM 8.9% 76% evidence | 15.9/20 P/E 12.2× · PEG 0.24 65% evidence | 8.5/20 RS sector -7% · RS bench 2.8% · 1Y 25.6%1 of 12 weeks ahead 70% evidence |
| Exact sum: 14 + 7.9 + 15.9 + 8.5 = 46.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 18Enerflex Ltd.EFXT | 45.8/100Mixed-negative evidence81% evidence | ASLEEP | 16.1/35 Revenue 11.8% · PAT 12.2% · OPM change -1.3 pp 83% evidence | 11.6/25 ROCE 3.7% · OPM 11.6% 76% evidence | 6.6/20 P/E 31.3× · PEG 2.31 65% evidence | 11.5/20 RS sector 3.9% · RS bench 10.5% · 1Y 144.2%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.1 + 11.6 + 6.6 + 11.5 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Innovex International, Inc.INVX | 45.4/100Mixed-negative evidence75% evidence | TURNING | 10.0/35 Revenue 26.4% · PAT -63.6% · OPM change -18.2 pp 83% evidence | 4.6/25 ROCE -2% · OPM -9.1% 76% evidence | 15.1/20 P/E 32.5× · PEG 0.1 65% evidence | 15.7/20 RS sector 10.8% · RS bench 20.9% · 1Y 95.2%3 of 12 weeks ahead 70% evidence |
| Exact sum: 10 + 4.6 + 15.1 + 15.7 = 45.4 · Decision use: Price leads the evidence: RS versus the benchmark is 20.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 20Flowco Holdings Inc.FLOC | 45.2/100Mixed-negative evidence71% evidence | ASLEEP | 19.1/35 Revenue 17.7% · PAT 45.6% · OPM change -1.1 pp 83% evidence | 12.3/25 ROCE 2.2% · OPM 17.3% 76% evidence | 10.9/20 P/E 17.6× · PEG — 15% evidence | 2.9/20 RS sector -15.8% · RS bench -8.2% · 1Y 26.9%1 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 12.3 + 10.9 + 2.9 = 45.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Weatherford International plcWFRD | 39.6/100Thin evidence · provisional58% evidence | ASLEEP | 13.4/35 Revenue — · PAT — · OPM change -1.2 pp 45% evidence | 11.5/25 ROCE 2.9% · OPM 10.7% 76% evidence | 11.1/20 P/E 16.1× · PEG — 15% evidence | 3.6/20 RS sector -12.9% · RS bench -5.2% · 1Y 61.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13.4 + 11.5 + 11.1 + 3.6 = 39.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 22RPC, Inc.RES | 37.8/100Thin evidence · provisional52% evidence | ASLEEP | 16.1/35 Revenue — · PAT — · OPM change -3.1 pp 45% evidence | 8.2/25 ROCE 1.2% · OPM 0.6% 76% evidence | 9.5/20 P/E 64.8× · PEG — 15% evidence | 4.0/20 RS sector -16.7% · RS bench -8.9% · 1Y 29.5%1 of 12 weeks ahead 70% evidence |
| Exact sum: 16.1 + 8.2 + 9.5 + 4 = 37.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Liberty Energy Inc.LBRT | 34.6/100Thin evidence · provisional58% evidence | ASLEEP | 17.0/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 7.2/25 ROCE 0.4% · OPM 2.2% 76% evidence | 9.8/20 P/E 35.4× · PEG — 15% evidence | 0.6/20 RS sector -22.9% · RS bench -18.1% · 1Y 79.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 7.2 + 9.8 + 0.6 = 34.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Expro Group Holdings N.V.XPRO | 34.3/100Thin evidence · provisional52% evidence | TURNING | 12.7/35 Revenue — · PAT — · OPM change -1.7 pp 45% evidence | 5.2/25 ROCE 0.6% · OPM 0.9% 76% evidence | 8.9/20 P/E 82.1× · PEG — 15% evidence | 7.5/20 RS sector -7.7% · RS bench 1.4% · 1Y 63.1%0 of 12 weeks ahead 70% evidence |
| Exact sum: 12.7 + 5.2 + 8.9 + 7.5 = 34.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25ProPetro Holding Corp.PUMP | 33.5/100Thin evidence · provisional52% evidence | ASLEEP | 14.8/35 Revenue — · PAT — · OPM change -5.6 pp 45% evidence | 4.5/25 ROCE -0.2% · OPM -3% 76% evidence | 8.6/20 P/E 951× · PEG — 15% evidence | 5.6/20 RS sector -11.6% · RS bench -6.4% · 1Y 136.3%3 of 12 weeks ahead 70% evidence |
| Exact sum: 14.8 + 4.5 + 8.6 + 5.6 = 33.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26Helix Energy Solutions Group, Inc.HLX | 31.0/100Adverse evidence65% evidence | ASLEEP | 6.7/35 Revenue -2.9% · PAT -83.5% · OPM change -7.5 pp 83% evidence | 4.0/25 ROCE -0.6% · OPM -4.6% 76% evidence | 8.7/20 P/E 98.9× · PEG — 15% evidence | 11.6/20 RS sector -1.3% · RS bench 7.3% · 1Y 64.4%0 of 12 weeks ahead 70% evidence |
| Exact sum: 6.7 + 4 + 8.7 + 11.6 = 31 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Atlas Energy Solutions Inc.AESI | 18.5/100Adverse evidence71% evidence | ASLEEP | 4.8/35 Revenue -8.3% · PAT -391.2% · OPM change -17.4 pp 83% evidence | 4.5/25 ROCE -1.6% · OPM -12.2% 76% evidence | 8.8/20 P/E 95.5× · PEG — 15% evidence | 0.4/20 RS sector -27.6% · RS bench -20.9% · 1Y -6.6%8 of 12 weeks ahead 100% evidence |
| Exact sum: 4.8 + 4.5 + 8.8 + 0.4 = 18.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28EagleRock Land, LLCEROK | 52.4/100Thin evidence · provisional21% evidence | 18.1/35 Revenue — · PAT — · OPM change 18.2 pp 7% evidence | 14.3/25 ROCE 7.2% · OPM 40.9% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 18.1 + 14.3 + 10 + 10 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29WaterBridge Infrastructure LLCWBI | 46.2/100Thin evidence · provisional36% evidence | BREAKING OUT | 17.9/35 Revenue — · PAT — · OPM change -0.9 pp 39% evidence | 9.8/25 ROCE 1.3% · OPM 15.2% 76% evidence | 8.5/20 P/E 1040.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —10 of 12 weeks ahead 0% evidence |
| Exact sum: 17.9 + 9.8 + 8.5 + 10 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30NextDecade CorporationNEXT | 39.2/100Thin evidence · provisional47% evidence | ASLEEP | 18.1/35 Revenue — · PAT — · OPM change — 33% evidence | 5.8/25 ROCE -0.5% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.3/20 RS sector -24.4% · RS bench -15.3% · 1Y -36.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 5.8 + 10 + 5.3 = 39.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is TechnipFMC plc's stock price today?
TechnipFMC plc trades at $70.0, +98.2% over the past year. The company is valued at $27.0 B. The stock sits at 84% of its 52-week range of $35–$77, +16.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 68 weeks in. — as of 5 August 2026.
What were TechnipFMC plc's latest quarterly results?
TechnipFMC plc reported revenue of $2.5 B and net profit of $0.3 B for the Mar 26 quarter. Revenue rose 11.7% and profit rose 85.7% year on year. Earnings per share were $0.64. The operating margin was 14.1%, 2.4 pp higher than a year earlier. — as of 5 August 2026.
What is TechnipFMC plc's revenue?
TechnipFMC plc reported revenue of $2.5 B in the Mar 26 quarter, +11.7% year on year. For the full FY25 fiscal year, revenue was $9.9 B (+9.4%). Over the last 4 years revenue compounded at 11.6% a year. — as of 5 August 2026.
What is TechnipFMC plc's profit?
TechnipFMC plc earned $0.3 B of net profit in the Mar 26 quarter, +85.7% year on year. Full-year FY25 profit was $1.0 B. The operating margin ran 14.1% in the latest quarter. — as of 5 August 2026.
What is TechnipFMC plc's market cap?
TechnipFMC plc's market capitalisation is $27.0 B at a stock price of $70.0. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is TechnipFMC plc's P/E ratio?
TechnipFMC plc trades at a P/E of 24.4×, at the 55th percentile of its own 3-year range, against a long-run median of 22.1×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does TechnipFMC plc pay a dividend?
Yes — TechnipFMC plc declared $0.05 per share for Mar 26, and $0.20 per share across the last four reported quarters. — as of 5 August 2026.
What is TechnipFMC plc's dividend per share?
TechnipFMC plc's most recently declared dividend is $0.05 per share for Mar 26, giving $0.20 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is TechnipFMC plc's dividend yield?
TechnipFMC plc's trailing dividend yield is 0.29%: $0.20 declared per share across the last four reported quarters, against a share price of $70.0. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is TechnipFMC plc overvalued?
On its own history, TechnipFMC plc looks mid-range against its own history: its P/E of 24.4× sits at the 55th percentile of its 3-year range (long-run median 22.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.
Is TechnipFMC plc growing?
Yes — TechnipFMC plc is growing: latest-quarter revenue +11.7% year on year, profit +85.7%, and the margin +2.4 pp at 14.1%. The 4-year compound rates are 11.6% (revenue) and 81.2% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is TechnipFMC plc performing?
TechnipFMC plc is in a confirmed uptrend, 68 weeks in. Its latest quarter's revenue rose 11.7% and profit rose 85.7% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is TechnipFMC plc in?
Mixed — no clean majority across the growth curves, ROCE lifting at 27.5% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +9.8% latest, profit growth +85.7% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is TechnipFMC plc in an uptrend?
Yes — the price is in a confirmed uptrend (week 68 of stage 2), trading +16.1% versus its 200-day average and at 84% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is TechnipFMC plc beating the market?
Not lately — on a trailing-13-week view TechnipFMC plc is currently behind the S&P 500 (8 weeks and counting; last ahead the week of 2026-06-12), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 9.5 years the stock moved +105% against the S&P 500's +240% — behind the index over the full window. — as of 5 August 2026.
Will TechnipFMC plc's stock price go up?
This page publishes no price forecast for TechnipFMC plc. What it measures instead: the stock price is $70.0, the price is in a confirmed uptrend 68 weeks in. Its P/E of 24.4× sits at the 55th percentile of its own 3-year range. — as of 5 August 2026.
Is the market betting against TechnipFMC plc?
Somewhat — short interest is 4.4% of TechnipFMC plc's tradable float, about 3.4 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does TechnipFMC plc have too much debt?
It is moderate — TechnipFMC plc's debt-to-equity is 0.38. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is TechnipFMC plc's capex?
TechnipFMC plc spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.3 B. — as of 5 August 2026.
What is TechnipFMC plc's cash flow?
TechnipFMC plc generated $1.8 B of operating cash flow in FY25 and $1.5 B of free cash flow after $0.3 B of capital spending. Reported profit that year was $1.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is TechnipFMC plc's profit real cash?
Yes — over the last 3 fiscal years, 184% of TechnipFMC plc's reported profit arrived as operating cash. In FY25, operating cash was $1.8 B against reported profit of $1.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is TechnipFMC plc?
On the balance sheet, the Z-score reads 2.84 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.
Where is TechnipFMC plc in its business cycle?
TechnipFMC plc's FY25 operating margin was 13.3%, against a 5-year band of 0.5%–13.3%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 14.1%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the TechnipFMC plc story?
The sharpest disagreement: the price moved +98.2% in a year while annual EPS moved +20.4% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is TechnipFMC plc a stock worth studying right now?
This is not investment advice. The machine read: TechnipFMC plc is printing record margins on a fuller multiple. From here the earnings must do all the lifting. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.